Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed), beta | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | glutaminase | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | breast cancer 1, early onset | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | polymerase (DNA directed), beta | 335 aa | 303 aa | 32.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0058 | 0.0276 | 0.0297 | |
Echinococcus granulosus | vesicular acetylcholine transporter | 0.0898 | 0.5957 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.033 | 0.2115 | 0.2115 |
Loa Loa (eye worm) | glutaminase | 0.033 | 0.2115 | 0.2115 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0365 | 0.2349 | 0.217 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0102 | 0.0102 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0192 | 0.1182 | 0.5 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.1496 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0098 | 0.0098 |
Brugia malayi | hypothetical protein | 0.0286 | 0.1814 | 0.1814 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0176 | 0.0126 |
Schistosoma mansoni | glutaminase | 0.033 | 0.2115 | 0.3438 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0176 | 0.0126 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.1496 | 1 | 1 |
Brugia malayi | glutaminase DH11.1 | 0.033 | 0.2115 | 0.2115 |
Loa Loa (eye worm) | vesicular acetylcholine transporter unc-17 | 0.0898 | 0.5957 | 0.5957 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0173 | 0.105 | 0.084 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0176 | 0.0126 |
Mycobacterium ulcerans | glutaminase | 0.033 | 0.2115 | 1 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0276 | 0.0276 |
Schistosoma mansoni | vesicular acetylcholine transporter | 0.0898 | 0.5957 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0176 | 0.5 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0102 | 0.0102 |
Loa Loa (eye worm) | hypothetical protein | 0.0764 | 0.5053 | 0.5053 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0176 | 0.0126 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.1814 | 0.2924 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0102 | 0.0102 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0102 | 0.0102 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0176 | 0.5 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0365 | 0.2349 | 0.1452 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0365 | 0.2349 | 0.217 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.1814 | 0.2924 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0176 | 0.5 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0176 | 0.0176 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0276 | 0.0297 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.1814 | 0.1814 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0365 | 0.2349 | 0.217 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0102 | 0.0102 |
Brugia malayi | vesicular acetylcholine transporter unc-17 | 0.0898 | 0.5957 | 0.5957 |
Trichomonas vaginalis | glutaminase, putative | 0.033 | 0.2115 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0176 | 0.5 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0276 | 0.0297 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0062 | 0.0305 | 0.0078 |
Toxoplasma gondii | hypothetical protein | 0.0059 | 0.028 | 0.5 |
Echinococcus multilocularis | vesicular acetylcholine transporter | 0.0898 | 0.5957 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0173 | 0.105 | 0.084 |
Loa Loa (eye worm) | hypothetical protein | 0.1496 | 1 | 1 |
Leishmania major | C-8 sterol isomerase-like protein | 0.1496 | 1 | 1 |
Onchocerca volvulus | Vesicular acetylcholine transporter homolog | 0.0898 | 0.5957 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.1585 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 3.1623 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.8048 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 21.1923 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.